Terms ending in 2040
Every in-force patent on AstraZeneca AB's record whose computed term ends in 2040, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,603,523 | PCSK9 Inhibitors and Methods of Use Thereof In force · High confidence | Astra Zeneca AB | In force | High confidence | |
| US 12,552,807 | PCSK9 Inhibitors and Methods of Use Thereof In force · Low confidence | AstraZeneca AB | In force | Low confidence | |
| US 12,584,120 | PCSK9 Inhibitors and Methods of Use Thereof In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 11,248,001 | PCSK9 Inhibitors and Methods of Use Thereof In force · High confidence | Astra Zeneca AB | In force | High confidence | |
| US 12,059,424 | Pharmaceutical Compositions Comprising (2S)-N-{(1S)-1-Cyano-2-[4-(3-Methyl-2-OXO-2,3-Dihydro-1,3-Benzoxazol-5-yl)PHENYL]ETHYL}-1,4-Oxazepane-2-Carboxamide In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 10,973,836 | Methods of Treating Heart Failure with Reduced Ejection Fraction In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 11,903,955 | Methods of Treating Heart Failure with Reduced Ejection Fraction In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 11,446,292 | Compounds and Conjugates Thereof In force · Medium confidence | MedImmune Limited | In force | Medium confidence | |
| US 12,509,702 | Inducible Modification of a Cell Genome In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 11,325,906 | Chemical Compounds In force · High confidence | AstraZeneca AB | In force | High confidence | |
| 4 more term ends in 2040 · Pro | |||||
10 of 14 patents shown. Soonest term end first, then patent number.
Pro members see all 14.
11 of these are in force and held by AstraZeneca AB.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.